{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:31:50Z","timestamp":1789968710858,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.carpath.2018.11.002","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T03:02:02Z","timestamp":1543633322000},"page":"12-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Lysosomal storage disorders affecting the heart: a review"],"prefix":"10.1016","volume":"39","author":[{"given":"Vidhya","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Belanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Veinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.carpath.2018.11.002_bb0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson\u2013Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.carpath.2018.11.002_bb0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ncb0905-847","article-title":"The lysosome turns fifty","volume":"7","author":"de Duve","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.carpath.2018.11.002_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/01913123.2011.601404","article-title":"Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment","volume":"35","author":"Hicks","year":"2011","journal-title":"Ultrastruct Pathol"},{"issue":"6","key":"10.1016\/j.carpath.2018.11.002_bb0020","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"Reuser A; GAA Database Consortium. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.carpath.2018.11.002_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","article-title":"Pompe disease: from pathophysiology to therapy and back again","volume":"6","author":"Lim","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.carpath.2018.11.002_bb0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ncl.2014.04.010","article-title":"Pompe disease: literature review and case series","volume":"32","author":"Dasouki","year":"2014","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.carpath.2018.11.002_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"10.1016\/j.carpath.2018.11.002_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.carpath.2018.11.002_bb0045","unstructured":"Wenger NK, Goodwin JF, Roberts WC. Cardiomyopathy and myocardial involvement in systemic disease. In: Hurst WH, editor in chief, Logue RB, Rackely CE, Schlant RC, Sonenblick EH, Wallace AG, Wenger NK, editors. Hurst's the heart, 6th ed: McGraw Hill Book Company; 1986, p.1181\u20131249."},{"issue":"6","key":"10.1016\/j.carpath.2018.11.002_bb0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1378\/chest.32.6.636","article-title":"Glycogen storage disease of the myocardium","volume":"32","author":"Mazzitello","year":"1957","journal-title":"Dis Chest"},{"issue":"1","key":"10.1016\/j.carpath.2018.11.002_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","article-title":"The genotype-phenotype correlation in Pompe disease","volume":"160C","author":"Kroos","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.carpath.2018.11.002_bb0060","series-title":"Cardiovascular pathology","first-page":"493","article-title":"Cardiovascular effects of systemic diseases and conditions","author":"Lester","year":"2001"},{"key":"10.1016\/j.carpath.2018.11.002_bb0065","series-title":"Ultrastructural pathology of the cell and matrix, volume 2","article-title":"Lysosomes","author":"Ghadially","year":"1997"},{"issue":"Suppl.1","key":"10.1016\/j.carpath.2018.11.002_bb0070","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1542\/peds.2016-0280C","article-title":"Newborn screening for Pompe disease","volume":"140","author":"Bodamer","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.carpath.2018.11.002_bb0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.carpath.2016.07.005","article-title":"A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review","volume":"25","author":"Bottillo","year":"2016","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"10.1016\/j.carpath.2018.11.002_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/20009666.2017.1324239","article-title":"Danon disease for the cardiologist: case report and review of the literature","volume":"7","author":"D'souza","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.carpath.2018.11.002_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.carpath.2018.11.002_bb0090","first-page":"79","article-title":"LAMP-2 deficiency (Danon disease)","volume":"26","author":"Di Mauro","year":"2007","journal-title":"Acta Myol"},{"key":"10.1016\/j.carpath.2018.11.002_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2016.06.311","article-title":"Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease","volume":"221","author":"Stokes","year":"2016","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.carpath.2018.11.002_bb0100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1747-0803.2007.00132.x","article-title":"Danon disease as a cause of autophagic vacuolar myopathy","volume":"2","author":"Yang","year":"2007","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.carpath.2018.11.002_bb0105","series-title":"Diagnostic pathology cardiovascular","first-page":"1","article-title":"LAMP2 mutation (Danon DISEASE)","author":"Butany","year":"2014"},{"issue":"5","key":"10.1016\/j.carpath.2018.11.002_bb0110","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s10545-007-0586-y","article-title":"Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I","volume":"30","author":"Soliman","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.carpath.2018.11.002_bb0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.carpath.2018.11.002_bb0120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004310050872","article-title":"Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders \u2014 clinical and echocardiographic findings in 64 patients","volume":"157","author":"Dangel","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.carpath.2018.11.002_bb0125","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S1047951109003576","article-title":"The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses","volume":"19","author":"Fesslov\u00e1","year":"2009","journal-title":"Cardiol Young"},{"key":"10.1016\/j.carpath.2018.11.002_bb0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.85.1.188","article-title":"Valvular heart disease in four patients with Maroteaux\u2013Lamy syndrome","volume":"85","author":"Tan","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2018.11.002_bb0135","first-page":"487","article-title":"The heart in the Hurler syndrome. Gross, histologic and ultrastructural observations in five necropsy cases","volume":"38","author":"Renteria","year":"1976","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.carpath.2018.11.002_bb0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.carpath.2014.01.001","article-title":"Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review","volume":"23","author":"Braunlin","year":"2014","journal-title":"Cardiovasc Pathol"},{"issue":"12","key":"10.1016\/j.carpath.2018.11.002_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122004","article-title":"Aortic root dilatation in mucopolysaccharidosis I\u2013VII","volume":"17","author":"Bolourchi","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"8249","key":"10.1016\/j.carpath.2018.11.002_bb0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.carpath.2018.11.002_bb0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-017-0052-4","article-title":"Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I","volume":"40","author":"Penati","year":"2017","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.carpath.2018.11.002_bb0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1590\/S1516-31802002000300008","article-title":"Gaucher's disease with myocardial involvement in pregnancy","volume":"120","author":"Torloni","year":"2002","journal-title":"Sao Paulo Med J"},{"issue":"2","key":"10.1016\/j.carpath.2018.11.002_bb0165","first-page":"211","article-title":"Gaucher's disease with valve calcification: possible role of Gaucher cells, bone matrix proteins and integrins","volume":"15","author":"Veinot","year":"1999","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.carpath.2018.11.002_bb0170","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/jnnp.36.6.1053","article-title":"Anderson\u2013Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain","volume":"36","author":"Kahn","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.carpath.2018.11.002_bb0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.carpath.2018.11.002_bb0180","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCEP.114.002569","article-title":"Pathology and function of conduction tissue in Fabry disease cardiomyopathy","volume":"8","author":"Frustaci","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.carpath.2018.11.002_bb0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-014-9452-9","article-title":"Anderson\u2013Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment","volume":"20","author":"Putko","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.carpath.2018.11.002_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1012475908718","article-title":"Renal disease in Fabry patients","volume":"24","author":"Grunfeld","year":"2001","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.carpath.2018.11.002_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1012428009627","article-title":"Cardiac manifestations in Fabry disease","volume":"24","author":"Linhart","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.carpath.2018.11.002_bb0200","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.2174\/13816128113199990387","article-title":"Neurological complications of Anderson\u2013Fabry disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"447","key":"10.1016\/j.carpath.2018.11.002_bb0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1651-2227.2005.tb02103.x","article-title":"Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapy","volume":"94","author":"Shah","year":"2005","journal-title":"Acta Paediatr Suppl"},{"issue":"7","key":"10.1016\/j.carpath.2018.11.002_bb0210","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00059-002-2429-9","article-title":"Fabry disease: focus on cardiac manifestations and molecular mechanisms","volume":"27","author":"Perrot","year":"2002","journal-title":"Herz"},{"issue":"7","key":"10.1016\/j.carpath.2018.11.002_bb0215","first-page":"883","article-title":"Clinical features, diagnosis, and management of patients with Anderson\u2013Fabry cardiomyopathy","volume":"33","author":"Yogasundaram","year":"2017","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.carpath.2018.11.002_bb0220","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.carpath.2018.11.002_bb0225","first-page":"21","article-title":"Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: a Fabry outcome survey analysis","volume":"3","author":"Beck","year":"2015","journal-title":"Mol Genet Metab Rep"},{"issue":"12","key":"10.1016\/j.carpath.2018.11.002_bb0230","first-page":"1706","article-title":"Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment","volume":"30","author":"Yogasundaram","year":"2014","journal-title":"Can J Cardiol"},{"issue":"1109","key":"10.1016\/j.carpath.2018.11.002_bb0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/postgradmedj-2017-135236","article-title":"Hydroxychloroquine-induced restrictive cardiomyopathy: a case report","volume":"94","author":"Dogar","year":"2018","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1016\/j.carpath.2018.11.002_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy","volume":"109","author":"Arad","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.carpath.2018.11.002_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12881-017-0512-6","article-title":"Cardiac manifestations of PRKAG2 mutation","volume":"19","author":"Banankhah","year":"2018","journal-title":"BMC Med Genet"},{"issue":"4","key":"10.1016\/j.carpath.2018.11.002_bb0250","first-page":"385","article-title":"Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management","volume":"40","author":"Meyers","year":"2013","journal-title":"Tex Heart Inst J"},{"issue":"5","key":"10.1016\/j.carpath.2018.11.002_bb0255","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0002-9440(10)65738-0","article-title":"Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy","volume":"153","author":"Arbustini","year":"1998","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.carpath.2018.11.002_bb0260","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.carpath.2018.11.002_bb0265","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12265-009-9124-7","article-title":"Hypertrophic cardiomyopathy: preclinical and early phenotype","volume":"2","author":"Ho","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"10.1016\/j.carpath.2018.11.002_bb0270","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2559.2004.01835.x","article-title":"The pathology of hypertrophic cardiomyopathy","volume":"44","author":"Hughes","year":"2004","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.carpath.2018.11.002_bb0275","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmoldx.2012.09.002","article-title":"Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era","volume":"15","author":"Teekakirikul","year":"2013","journal-title":"J Mol Diagn"},{"issue":"7","key":"10.1016\/j.carpath.2018.11.002_bb0280","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCRESAHA.116.309348","article-title":"Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation","volume":"121","author":"Nishimura","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2018.11.002_bb0285","series-title":"Fabry disease: perspectives from 5 years of FOS","article-title":"Laboratory diagnosis of lysosomal storage diseases","author":"Bekri","year":"2006"},{"key":"10.1016\/j.carpath.2018.11.002_bb0290","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.2004-0583","article-title":"Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy","volume":"114","author":"Meikle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.carpath.2018.11.002_bb0295","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(75)90119-9","article-title":"Oligosaccharides in urine of patients with glycoprotein storage diseases. I. Rapid detection by thin-layer chromatography","volume":"60","author":"Humbel","year":"1975","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.carpath.2018.11.002_bb0300","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2004.07.015","article-title":"Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in uteroindicators of lysosomal storage diseases","volume":"83","author":"Ramsay","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.carpath.2018.11.002_bb0305","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities and the development of neurological disorders","volume":"6","author":"Conzelmann","year":"1983","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.carpath.2018.11.002_bb0310","doi-asserted-by":"crossref","first-page":"293e9","DOI":"10.1016\/0009-8981(78)90328-5","article-title":"Alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state","volume":"89","author":"Taniguchi","year":"1978","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.carpath.2018.11.002_bb0315","doi-asserted-by":"crossref","first-page":"9e19","DOI":"10.1016\/0009-8981(85)90295-5","article-title":"Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells","volume":"148","author":"Shin","year":"1985","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.carpath.2018.11.002_bb0320","doi-asserted-by":"crossref","first-page":"1318e25","DOI":"10.1093\/clinchem\/46.9.1318","article-title":"Determination of acid alpha-glucosidase protein: evaluation as a screening marker for Pompe disease and other lysosomal storage disorders","volume":"46","author":"Umapathysivam","year":"2000","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.carpath.2018.11.002_bb0325","first-page":"156","article-title":"Lysosomal storage disorders: molecular basis and laboratory testing. Hum Genomics","volume":"5","author":"Filocamo","year":"2011"},{"issue":"1","key":"10.1016\/j.carpath.2018.11.002_bb0330","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijmm.2012.1187","article-title":"New strategies for the treatment of lysosomal storage diseases (review)","volume":"31","author":"Parenti","year":"2013","journal-title":"Int J Mol Med"},{"issue":"Suppl. 1","key":"10.1016\/j.carpath.2018.11.002_bb0335","first-page":"639","article-title":"Combination therapies for lysosomal storage diseases: a complex answer to a simple problem","volume":"13","author":"Macauley","year":"2016","journal-title":"Pediatr Endocrinol Rev"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880718303004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880718303004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:45:03Z","timestamp":1760960703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880718303004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":67,"alternative-id":["S1054880718303004"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2018.11.002","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosomal storage disorders affecting the heart: a review","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2018.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}